Summary of Conference Call Records Industry or Company Involved - **Zhejiang Zhenyuan**: Focused on biotechnological synthesis and amino acid production - **Guohang**: Engaged in international cargo transportation and logistics Core Points and Arguments - **Zhejiang Zhenyuan's Project**: The company is advancing its biological directed synthesis project, specifically for hydrochloride histidine, with all sections of the project nearly installed and testing underway. Production is expected to commence in Q3 2025. Hydrochloride histidine serves as a starting raw material for synthesizing ergotamine [5][6] - **Investment in Synthetic Biology**: Zhejiang Zhenyuan has invested significantly in synthetic biology over the years, collaborating with renowned research institutions such as the Tianjin Institute of Industrial Biotechnology and East China University of Science and Technology. This has led to the development of advanced synthetic biology technologies for large-scale production of various amino acids, which are crucial for food additives, health supplements, and pharmaceutical intermediates [5][6] - **Guohang's International Operations**: Guohang's international cargo routes cover 21 cities across 12 countries, with new routes planned for 2024, including Guangzhou to Mexico City. The company is leveraging passenger aircraft for cargo transport, enhancing its service capabilities in line with the Belt and Road Initiative. A new cargo route from Chengdu to Dubai is set to open in April 2025 [5][6] Other Important but Possibly Overlooked Content - **Market Trends**: The top trending topics in the interactive platform include artificial intelligence, photovoltaics, and industrial robotics, indicating a strong market interest in these sectors [2] - **Emerging Technologies**: The company is also exploring developments in high-end CNC machine tools, smart control systems, and robotics, which are expected to drive future growth [6][7] - **Stock Performance**: Recent stock performance shows a +1.88% increase for Zhejiang Zhenyuan and a -2.54% decrease for Guohang, reflecting market reactions to their respective developments [7]

国泰海通研报称，相较以往各平台预售时间错峰，今年天猫、抖音、京东三大平台均将大促首日定为5 月13日，流量竞争更加激烈。美护板块结构性机会突出，"6.18"年中大促各平台延长活动周期、简化玩 法、加码扶持商家，企业发力产品创新升级、优化运营矩阵，品牌有望实现多点爆发。 商报讯(记者苗露)昨日，A股主要股指弱势下探，沪指再次失守3400点，截至下午收盘，沪指跌0.68%报 3380.82点，深证成指跌1.62%报10186.45点，创业板指跌1.91%报2043.25点，科创50指数跌1.26%。场内 超3800股飘绿，总体来看个股跌多涨少。港股亦走低，恒生指数跌近1%，恒生科技指数跌1.5%。 盘面上，大消费领域多个方向表现亮眼，化妆品、服装、乳业板块纷纷走强；宠物经济板块震荡走高， 合成生物概念活跃，港口航运板块拉升，券商、军工、半导体等板块回调。 大消费领域多个板块强势拉升 昨日，大消费领域多个方向表现亮眼，也让关注消费赛道的投资者信心倍增。 据同花顺（300033）数据，昨日美容护理板块跃居当日行业板块排名第一，整体收涨6.46%，33只成分 股中31只上涨；细分板块中的化妆品板块领涨A股，个股"0"下 ...

Group 1 - The report highlights a significant liquidity event with a reduction in reserve requirements, yet non-bank borrowing costs unexpectedly increased, indicating a divergence in market behavior [4][5][6] - The stock market is experiencing a correction phase following a narrative of "fund repositioning," with major indices showing declines, particularly in technology sectors [2][8] - The commodity market is witnessing mixed performances, with precious metals showing signs of stabilization after recent declines, while industrial metals exhibit varied trends [3][6] Group 2 - The report identifies three potential reasons for the unexpected tightening of liquidity post-reduction in reserve requirements, including significant government bond issuance and the maturity of large repurchase agreements [6][7] - The technology sector is under pressure due to concerns over liquidity and repositioning strategies, leading to notable declines in major tech indices [8][9] - The Hong Kong stock market is also experiencing a shift, with net outflows from technology stocks, suggesting a changing investment focus towards dividend-paying stocks [9]

Market Overview - On May 15, major market indices collectively declined, with the Shanghai Composite Index falling by 0.68% and the ChiNext Index dropping nearly 2% [1] - The total trading volume in A-shares reached 1.19 trillion yuan, with over 1,400 stocks closing higher, including 78 stocks hitting the daily limit [1] Sector Performance - The beauty and personal care sector led the gains, closing up 3.68%, with stocks like Qingsong Co., Huaye Fragrance, and Jieya Co. hitting the daily limit [1] - The port and shipping sector experienced a pullback after an initial rise, with stocks such as Nanjing Port and Ningbo Maritime continuing to hit the daily limit [1] - The synthetic biology concept index rose over 2%, with 10 stocks hitting the daily limit, including Chuaning Biology and Meinong Biology [1] Historical Highs - A total of 28 stocks reached historical closing highs, with the beauty and personal care, banking, and machinery sectors showing significant concentration [2] - The average increase for stocks that reached historical highs was 6.87%, with notable gainers including Babi Co., Dengkang Oral, and Ruoyuchen [2] Institutional Trading - On May 15, 14 stocks faced net selling by institutions exceeding 10 million yuan, with Youfu Co. leading the sell-off at 146 million yuan [4] - Only 8 stocks saw net buying from institutions, with Aerospace Nanhu and Yuzhong Three Gorges A receiving over 10 million yuan in net purchases [4] Northbound Capital Flow - Northbound capital saw net buying in 5 stocks, with Jilin Chemical Fiber leading at 33.01 million yuan, followed by Jingyun Tong at 28.59 million yuan [6] - Aerospace Nanhu experienced the highest net selling among northbound funds, amounting to 50.41 million yuan [6] Company Announcements - Feilong Co. received a project designation notice from a well-known domestic automotive brand, becoming a supplier for a thermal management module [7] - Yuyue Medical's automatic external defibrillator (AED) product obtained EU MDR certification [8] - Heng Rui Pharmaceutical completed a share repurchase of 12.90 million shares, accounting for 0.2% of its total share capital, with a total transaction amount of 601 million yuan [8]

（原标题：和讯投顾许寒：高低切节点，接替化工的炒作主线已明牌） 再看化工抱团，益达今日冲高回落放出近期天量，明日是低开的预期，而三峡今日虽然顶着益达和保利 的负反馈勉强封板，但盘中炸板频频，明日一个涨停就严重异动了，所以此三峡的抱团也只是化工鱼尾 的绝唱，而尤夫的尾盘封板走的是跨境的外贸预期，明日有冲高的预期，若冲高回落无大单承接需要及 时分手，而君君的小成飞今日以t字换手之姿突破700魔咒，且全天分时无任何漏单技巧，虽然表现强 劲，但是对后排无任何带动作用，中行也没有强势翻红。这符合峰哥昨天对君君的判断，目前君君仍然 处于前排淘汰赛之中，那小程飞从封单质量来看，明日有冲高预期，但仍然需要经历放量换手的考验， 目前和三峡一样只能作为一个短线情绪锚定，如果成飞晋级成功，稳健型选手可以留意通达的绿肺缘 分，最后聊因一则小作文爆发的nm题材，川宁率先上板带动合成生物板块爆发题材，因业绩驱动更偏 趋势，走法爆发的后排涨停，中金达主动性更强，以趋势手法绿肥红瘦对待即可。 5月15日，和讯投顾许寒分析，接替化工的炒作主线已明牌，其中会出现有望对标三峡高度的低位，新 龙随着陈小群在亿达一键式清仓怒赚一个小目标，易达盘中高开 ...

★ 宏观动态 ★ 央行：拟进一步丰富"互换通"产品类型 据中国人民银行消息，为进一步促进内地与香港金融衍生品市场协同发展，推动金融高水平对外开放，中国人 民银行、香港证券及期货事务监察委员会、香港金融管理局在充分总结"互换通"运行经验、认真听取境内外投 资者意见建议的基础上，拟进一步丰富"互换通"产品类型。一是延长合约期限，延长利率互换合约期限至30 年，满足市场机构多样化风险管理需求；二是扩充产品谱系，推出以贷款市场报价利率（LPR）为参考利率的 利率互换合约。两地金融市场基础设施机构将陆续上线以上优化措施。下一步，内地与香港金融管理部门将继 续指导两地金融市场基础设施机构，根据"互换通"的运行情况，持续完善相关机制安排，稳步推动中国金融市 场进一步对外开放，稳慎扎实推进人民币国际化，支持香港国际金融中心繁荣发展。 最高法、证监会：对于"小作文"损害他人权益且构成犯罪的，依法追究刑事责任 最高人民法院、证监会联合发布《关于严格公正执法司法 服务保障资本市场高质量发展的指导意见》。意见 提到，依法打击编传虚假信息、"维权黑产"、发行上市环节不正当竞争等干扰市场正常运行、扰乱资本市场秩 序的违法行为，形成风清气 ...

（原标题：主力资金丨这些股被盯上，尾盘主力资金出手抢筹） 今日，5个行业主力资金净流入。 5月15日，A股三大指数集体回调。行业板块涨少跌多，美容护理板块大涨，食品饮料和化学制药等板块涨幅居前。 沪深两市全天主力资金净流出531.15亿元。医药生物、美容护理、煤炭、农林牧渔和轻工制造5个行业主力资金净流入，净流入金额分别为7.04亿 元、3.88亿元、2.72亿元、2.24亿元、2870.19万元。 26个主力资金净流出行业中，计算机行业主力资金净流出金额居首，为104.66亿元；电子和非银金融行业主力资金净流出均超50亿元；机械设 备、电力设备和通信行业主力资金净流出均超40亿元。 2股尾盘主力资金净流出超亿元 尾盘沪深两市主力资金净流出49.3亿元。建筑装饰、煤炭、建筑材料、农林牧渔等行业尾盘主力资金净流入均超2000万元。 个股方面，盛天网络尾盘主力资金净流入超6000万元；中航成飞、晨曦航空、宁波远洋、宁波海运主力资金净流入均超4000万元。 中际旭创和宁德时代尾盘主力资金净流出超亿元；中欣氟材、红宝丽、同花顺尾盘主力资金净流出均超6800万元。 7股主力资金净流入均超2亿元 从个股来看，沪深两市29 ...

Core Viewpoint - The domestic beauty brand market in China is experiencing strong growth, driven by increasing consumer recognition and confidence in local brands, as stated by the CEO of Marubi Biotechnology during the 2024 annual and Q1 2025 earnings presentation [1] Financial Performance - Marubi Biotechnology achieved a net profit attributable to shareholders of 342 million yuan for the fiscal year 2024, representing a year-on-year increase of 31.69%, while the net profit after deducting non-recurring gains and losses was 327 million yuan, up 73.86% year-on-year [1] - In Q1 2025, the company reported a net profit attributable to shareholders of 135 million yuan, a year-on-year increase of 22.07%, with the net profit after deducting non-recurring gains and losses at 134 million yuan, up 28.57% year-on-year [1] - The stock price of Marubi Biotechnology has increased by over 150% since September 2024, with a closing limit up on May 15 [1] Strategic Transformation - The company has undergone a strategic transformation from a traditional beauty enterprise to a biotechnology beauty company, as indicated by the renaming of its stock from "Marubi Co., Ltd." to "Marubi Biotechnology" in 2024 [2] - Marubi Biotechnology emphasizes the importance of biotechnology in its current and future operations, particularly in the development and industrial application of key technologies such as recombinant collagen protein [2] Research and Development - In 2024, Marubi Biotechnology was recognized as a "National Research Center for Recombinant Functional Protein Technology," conducting 20 specialized studies on recombinant functional proteins throughout the year [2] - The company has made significant advancements in the development of various types of recombinant collagen proteins and has filed for 10 invention patents related to key technologies [2] Industry Trends - The beauty industry is witnessing accelerated penetration of advanced technologies such as artificial intelligence, synthetic biology, and smart manufacturing, which are driving industry upgrades [3] - Consumer demand is becoming more diverse and personalized, leading to higher expectations for quality, efficacy, and added value in beauty products and services [3] Sales and Distribution Strategy - Marubi Biotechnology is pursuing a multi-channel collaborative development strategy, with its brands already present in duty-free stores and actively exploring other channel opportunities [3]

Group 1 - The pet economy concept rose by 1.98%, ranking third among concept sectors, with 54 stocks increasing in value, including major gainers like Meino Biological and Jieya Co., which hit the 20% limit up [1][2] - Notable stocks with significant increases include Xianle Health, Huisheng Biological, and Yiyuan Magic Yam, which rose by 13.41%, 10.50%, and 9.10% respectively [1] - The leading decliners in the sector were Zhiou Technology, Qingmu Technology, and Yingstone Network, which fell by 4.64%, 4.42%, and 2.73% respectively [1] Group 2 - The pet economy sector saw a net inflow of 236 million yuan, with 48 stocks receiving net inflows, and 7 stocks attracting over 30 million yuan each [2] - The top stock for net inflow was Yong'an Pharmaceutical, with a net inflow of 68.36 million yuan, followed by Jieya Co., Ruoyuchen, and Meino Biological with net inflows of 48.24 million yuan, 46.14 million yuan, and 45.47 million yuan respectively [2][3] Group 3 - In terms of net inflow ratios, Jieya Co., Jiabiyou, and Meino Biological led with net inflow rates of 27.98%, 13.31%, and 11.04% respectively [3] - The pet economy sector's inflow ranking included stocks like Yong'an Pharmaceutical, Jieya Co., Ruoyuchen, and Meino Biological, all showing strong performance in terms of trading volume and turnover rates [3][4]

合成生物概念资金流入榜 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 301301 | 川宁生 物 | 20.03 | 23.97 | 55836.64 | 28.09 | | 002626 | 金达威 | 9.99 | 4.82 | 15531.49 | 29.36 | | 600223 | 福瑞达 | 10.04 | 3.47 | 11105.16 | 40.03 | | 002422 | 科伦药 业 | 2.98 | 1.93 | 10625.04 | 12.06 | | 301089 | 拓新药 业 | 20.02 | 17.97 | 8736.29 | 18.23 | | 300132 | 青松股 份 | 20.08 | 21.04 | 6854.51 | 10.61 | | 300189 | 神农种 | 3.50 | 24.42 | 5681.73 | 6.00 | | | 业 | | | | | 截至5月 ...